Contact
searchSearch
HMP Global
CIO2022 Highlights

Edward Kim, MD, FSIR, Discusses the Updated Clinical and Dosimetric Recommendations for Y-90 Glass Microspheres in HCC

Edward Kim, MD
10/26/2022

Introduction

Dr Edward Kim discusses his CIO2022 abstract, "Updated Clinical and Dosimetric Recommendations for Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma." 

CLICK HERE TO READ THE FULL ABSTRACT AND VIEW POSTER

Video

Related Content

TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management
Case Report
Off-Label Flow Diverter Stent as a Salvage Technique for Early Post-Liver Transplant Hepatic Arterial Occlusion: A Novel Technique
07/15/2026
Santhosh Babu K.B, MBBS, MD, FNVIR; Ashish Goel, DM, MD; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case...
07/15/2026
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management
Transarterial Chemoembolization
STRIDE-Based Regimens Plus TACE Improve Outcomes vs TACE Alone in Embolization-Eligible Hepatocellular Carcinoma
07/13/2026
Stephanie Holland
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3...
07/13/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Hand Protection
Mölnlycke Launches Biogel Radiation Protection Gloves to Tackle Low Adoption of Hand Protection in Radiation-Guided Surgical Procedures
09/22/2026
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC....
09/22/2026
Cath Lab Digest
TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management
Medicare Reimbursement
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
09/01/2026
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1,...
09/01/2026
Vascular Disease Management
Pulmonary Embolism
PRAGUE-26 Trial: Evaluating Catheter-Directed Thrombolysis for Intermediate-High Risk Pulmonary Embolism Patients Versus Standard Anticoagulation Therapy Alone
09/01/2026
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial...
09/01/2026
Cath Lab Digest
NYU Langone
NYU Langone Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology
08/27/2026
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed...
08/27/2026
Vascular Disease Management
Bioresorbable Scaffolds
Abbott Secures CE Mark for Longer-Length Esprit BTK System for Severe PAD in Europe
08/26/2026
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit...
08/26/2026
Cath Lab Digest
Radiation Safety
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
08/20/2026
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company...
08/20/2026
Cath Lab Digest
Imaging of acute ischemic stroke
Stroke Treatment
Siemens Healthineers Receives ARPA-H Funding of up to $31M to Advance Remote Endovascular Robotics for Acute Stroke Treatment
08/20/2026
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential...
08/20/2026
Cath Lab Digest
Radiation-Reducing Tech
Hoag First in California to Bring Radiation-Reducing Technology to Complex Vascular Care
08/18/2026
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex aortic aneurysm repair at Hoag now have access to one of the most advanced image-guided technologies available.
Patients undergoing complex...
08/18/2026
Vascular Disease Management
pVasc NET (Vesalio)
Thrombectomy
Vesalio Announces FDA 510(k) Clearance of pVasc NET, a Next-Generation Peripheral Mechanical Thrombectomy Device With Integrated Distal Filter
08/17/2026
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s pVasc platform with integrated clot-capture technology designed to retain clot fragments during retrieval.
New device expands Vesalio’s...
08/17/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use